• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virusdisease . Exploration of antigenic determinants in spike glycoprotein of SARS-CoV2 and identification of five salient potential epitopes

tetano

Editor, Senior Moderator
Virusdisease


. 2021 Sep 7;1-10.
doi: 10.1007/s13337-021-00737-9. Online ahead of print.
Exploration of antigenic determinants in spike glycoprotein of SARS-CoV2 and identification of five salient potential epitopes


Aditya Agrawal[SUP] 1 [/SUP], Rajat Varshney[SUP] 2 [/SUP], Mamta Pathak[SUP] 1 [/SUP], Shailesh Kumar Patel[SUP] 1 [/SUP], Vishal Rai[SUP] 1 [/SUP], Sourabh Sulabh[SUP] 3 [/SUP], Rohini Gupta[SUP] 4 [/SUP], Khushal Singh Solanki[SUP] 1 [/SUP], Ritu Varshney[SUP] 5 [/SUP], Ramadevi Nimmanapalli[SUP] 2 [/SUP]



Affiliations

Abstract

Emerging pathogens have been an eternal threat to mankind. In a series of pandemics caused by notorious coronaviruses, a newly emerged SARS-CoV2 virus is creating panic among the world population. The unavailability of reliable theranostics insists the exploration of antigenic determinants in spike glycoprotein of SARS-CoV2. The four novel inserts ('[SUP]70[/SUP]VSGTNGT[SUP]76[/SUP]', '[SUP]150[/SUP]KSWM[SUP]153[/SUP]', [SUP]247[/SUP]SYLTPG[SUP]252[/SUP] and [SUP]674[/SUP]QTQTNSPRR[SUP]682[/SUP]) in SARS-CoV2 spike protein were unraveled via multiple sequence alignment of spike proteins of SARS-CoV2, SARS-CoV, and MERS-CoV. The three-dimension (3D) modeling of the spike protein of the SARS-CoV2 and their interaction with the ACE2 receptor was delineated with the help of SWISS-MODEL and 3DLigandSite web servers. The predicted 3D model of SARS-CoV2 was further verified by SAVES, RAMPAGE, and ProSA-web tools. The potential B-cell immunogenic epitopes of SARS-CoV2 were predicted out by using various software viz. IEDB B-cell epitopes prediction tool, BepiPred linear epitope prediction tool, Emini Surface Accessibility Prediction tool, and Kolaskar-Tongaonkar antigenicity web tool. The five epitopes (i.e. '[SUP]71[/SUP]SGTNGTKRFDN[SUP]81[/SUP], [SUP]247[/SUP]SYLTPG[SUP]252[/SUP], [SUP]634[/SUP]RVYST[SUP]638[/SUP], [SUP]675[/SUP]QTQTNSPRRARSV[SUP]687[/SUP], and [SUP]1054[/SUP]QSAPH[SUP]1058[/SUP]) were selected as potent antigenic determinants. The quantum of information generated by this study will prove beneficial for the development of effective therapeutics, diagnostics, and multi-epitopic vaccines to combat this ongoing menace.

Keywords: ACE2 receptor; Epitopes; SARS-CoV2; Spike protein; Vaccines.
 
Back
Top Bottom